Clinical outcomes of patients with breast cancer in a phase I clinic: the M. D. Anderson cancer center experience

Clinical Breast Cancer
Jennifer WhelerRazelle Kurzrock

Abstract

Patients with metastatic breast cancer (MBC) refractory to standard therapy have a poor prognosis. We assessed prognostic factors and clinical outcomes for patients with MBC referred to a phase I clinic focused primarily on targeted agents. We reviewed the medical records of sequential patients with MBC who presented to our phase I clinic between September 2004 and May 2008 to assess baseline patient characteristics, overall survival (OS), and clinical benefit. A total of 92 patients were identified, with a median age of 53 years (range, 28-83 years). The median number of previous therapies was 5 (range, 1-16 therapies). Of 92 patients, 78 were eligible for and offered > or = 1 phase I clinical trial. With a median follow-up of 7.4 months, the median OS was 6.7 months (95% CI, 5.2-9.7). In multivariate analysis, independent factors predicting shorter survival were > or = 10 previous treatments (vs. < 10 previous treatments; hazard ratio [HR], 3.27; 95% CI, 1.37-7.81; P = .008), Eastern Cooperative Oncology Group (ECOG) performance status (PS) 2/3 (vs. 0/1; HR, 2.92; 95% CI, 1.28-6.66; P = .01), and albumin level < 3.5 g/dL (vs. > 3.5 g/dL; HR, 2.88; 95% CI, 1.41-5.89; P = .004). Patients with locally advanced or metastatic brea...Continue Reading

References

Nov 7, 1990·Journal of the National Cancer Institute·R J CoatesR L Brown
Jun 9, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M PaesmansJ Klastersky
Dec 19, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J AlexandreF Goldwasser
Mar 5, 2004·Breast Cancer Research and Treatment·Mei WuSofia D Merajver
Nov 4, 2004·JAMA : the Journal of the American Medical Association·Thomas G RobertsJeffrey W Clark
Mar 5, 2005·The New England Journal of Medicine·Elizabeth HorstmannChristine Grady
Mar 5, 2005·The New England Journal of Medicine·Razelle Kurzrock, Robert S Benjamin
May 25, 2006·Clinical Pharmacokinetics·Kellie A CharlesStephen J Clarke
Dec 11, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·V Craig Jordan
Dec 25, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Rohini SharmaHani Gabra
Dec 28, 2007·The New England Journal of Medicine·Kathy MillerNancy E Davidson
Feb 22, 2008·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Mar 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maggie C U CheangTorsten O Nielsen
Jun 11, 2008·Breast Cancer Research and Treatment·Rebecca DentSteven A Narod
Jun 14, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Hendrik-Tobias ArkenauStan Kaye
Dec 11, 2008·Journal of the National Cancer Institute·K Robin YabroffEric J Feuer

❮ Previous
Next ❯

Citations

Feb 24, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M SchmidtM Schuler
Aug 18, 2016·Breast Cancer Research and Treatment·Fanny Le DuNaoto T Ueno
Jul 17, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·A SchwandtS P Ivy
Sep 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M SchmidtM Schuler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.